« Previous
Cancer Epidemiology
Volume 34, Issue 6
, Pages 733-740
, December 2010
Primary exploration of CDR3 spectratyping and molecular features of TCR β chain in the peripheral blood and tissue of patients with colorectal carcinoma
References
- . A direct estimate of the human alpha beta T cell receptor diversity. Science. 1999;286:958–961
- . Size estimation of alpha beta TCR repertoire of naive mouse spenocytes. J Immunol. 2000;164:5782–5787
- . Crystal structure of the beta chain of T cell antigen receptor. Science. 1995;247:1984–1987
- . Combination of MHC-peptide multimer-based T cell sorting with the immunoscope permits sensitive ex vivo quantitation an follow-up of human CD8+ T cell immune responses. J Immunol Methods. 2002;241:177–194
- A structural basis for the selection of dominant alpha beta T cell receptors in antiviral immunity. Immunity. 2003;18:53–64
- . A structural basis for immunodominant human T cell receptor recognition. Nat Immunol. 2003 l;4:657–663
- Analysis of the CDR3 region of alpha/beta T-cell receptors (TCRs) and TCR BD gene double-stranded recombination signal sequence breaks end in peripheral blood mononuclear cells of T-lineage acute lymphoblastic leukemia. Clin Lab Haematol. 2006;28:405–415
- . Limited T cell receptor V beta chain repertoire of liver-infiltrating T cells in autoimmune hepatitis. J Hepatol. 1998;28:70–77
- . Invariant or highly conserved TCR alpha are expressed on double-negative (CD3+CD4−CD8−) and CD8+ T cells. J Immunol. 1999;163:301–311
- . Development and validation of an externally standardized quantitative insulin-like growth factor-1 RT-PCR using light cycler SYBR green I technology. Rapid cycle real-time PCR, methods and applications. Berlin: Springer; 2001;p. 281–92
- . Retino VEGF mRNA measured by SYBR green I fluorescence: a versatile approach to quantitative PCR. Mol Vis. 2000;6:178–183
- Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996;384:134–141
- An alpha beta T cell receptor structure at 2.5
A and its orientation in the TCR–MHC complex. Science. 1996;274:209–219 - . The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain. EMBO J. 1997;16:4205–4216
- . Structure of the V delta domain of a human gamma delta T-cell antigen receptor. Nature. 1998;391:502–506
- . T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334:395–402
- . Rapid diagnosis of clonal immunoglobulin heavy chain gene rearrangements in cutaneous B-cell lymphomas using the light cycler polymerase chain reaction with DNA melting curve analysis. Am J Dermatopathol. 2004;26:385–389
- . Rapid detection of clonal T-cell receptor-beta gene rearrangements in T-cell lymphomas using the light cycler polymerase chain reaction with DNA melting curve analysis. J Mol Diagn. 2005;7:81–88
- . Long-term human coronavirus myelin cross-reactive T-cell clones derived from multiple sclerosis patients. Clin Immunol. 2007;123:258–267
- Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis. Eur J Immunol. 2007;37:849–863
- Development and application of a potential diagnostic test for hepatitis B patients: a gene melting spectral pattern assay for the TCRBV CDR3 gene. Hepatol Res. 2010;40(4):407–414
- . Comparative sequence analysis of the human T cell receptor TCRA and TCRB CDR3 regions. Hum Immunol. 1996;48:32–38
- . T cell receptor V beta repertoire usage and clonal expansion of T cells in chronic myelogenous leukemia. Chin Med J. 2004;117:840–843
- Analysis of the CDR3 length of TCR αβ+T cell in the peripheral blood of patients with chronic hepatitis B. Hepatol Res. 2006;35:10–18
- Junctional biases in the naïve TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Immunity. 2000;12:547–556
- T cell receptor V beta repertoire expression reflects gastric carcinoma progression. Clin Immunol. 2001;101:3–7
- Antigen-driven T cell selection in patients with cervical cancer as evidenced by T cell receptor analysis and recognition of autologous tumour. Clin Lab Immunol. 2002;9:247–278
- . Cancer immunotherapy: the past, the present and the future. Immunol Cell Bird. 2003;81:106–113
PII: S1877-7821(10)00116-5
doi: 10.1016/j.canep.2010.06.010
« Previous
Cancer Epidemiology
Volume 34, Issue 6
, Pages 733-740
, December 2010
